Werfel Asked To Clarify How To Treat R&D Costs In M&A
Accounting firm RSM US LLP, in a letter released Tuesday, asked Internal Revenue Commissioner Daniel Werfel to clarify how to treat research and development costs when a taxpayer disposes of an...To view the full article, register now.
Already a subscriber? Click here to view full article